Gladstone NOW: The Campaign Join Us on the Journey ✕
91 - 105 of 125 Results Clear All
Ten years ago, Shinya Yamanaka revolutionized biological research with his discovery of how to turn ordinary skin cells into stem cells with just four key genes.
Yamanaka Lab Stem Cells/iPSCs
Todd McDevitt has rapidly enchanced how Gladstone thinks about bioengineering and stem cell biology.
McDevitt Lab Stem Cells/iPSCs
Key proteins involved in gene expression depend on each other when forming a heart in an embryo. But, if left alone, they start to run amok.
Stem Cells/iPSCs Congenital Heart Disease
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
Diabetes Ding Lab Stem Cells/iPSCs
With support from the Wilsey Family, Gladstone is studying a rare genetic condition that could provide clues to curing a whole host of diseases.
Philanthropy Stem Cells/iPSCs Rare Diseases
The regenerative medicine program at the Gladstone Institutes has attracted the attention of two global business leaders known for their innovative approach to philanthropy.
Yamanaka Lab Philanthropy Stem Cells/iPSCs
Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.
Congenital Heart Disease Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
Gladstone Institutes is pleased to present the inaugural Ogawa-Yamanaka Stem Cell Prize to Masayo Takahashi, MD, PhD.
Awards News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
Using his unique chemical cocktail, Gladstone’s Sheng Ding has regenerated the cells that die in paralyzing spinal cord injuries.
Ding Lab Spinal Cord Injuries Stem Cells/iPSCs
The new system could serve as a drug-screening tool to make pregnancies safer.
Conklin Lab Stem Cells/iPSCs
The discovery of cell reprogramming by Shinya Yamanaka changed the way scientists see cell biology, but the details of how it works are still being defined. In a recent paper, the labs of Yamanaka and Bruce Conklin show how one key factor—NANOG—is involved in the process.
Conklin Lab Yamanaka Lab Stem Cells/iPSCs
Collaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.
Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
The new strategy is more sustainable and less risky than the current standard therapies.
McDevitt Lab Stem Cells/iPSCs
Scientists have discovered why some heart tissue turns into bone, and they may have learned how to stop it.
Srivastava Lab Stem Cells/iPSCs
The first study to manipulate CRISPR genome editing using small molecules has important implications for correcting disease-causing genetic mutations
Cardiovascular Disease Roddenberry Stem Cell Center Ding Lab CRISPR/Gene Editing Stem Cells/iPSCs
